Patents by Inventor Bradley Lawrence Hershey

Bradley Lawrence Hershey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240304289
    Abstract: A system (e.g., computing system) for analyzing user interaction associated with a neurostimulation treatment may include functionality to: receive user interaction data associated with a patient undergoing the neurostimulation treatment, with the user interaction data indicating attributes of one or more user interactions in a software platform (e.g., patient computing device) that collects user feedback relating to the neurostimulation treatment; identify attributes of the user interactions from the user interaction data; generate a task to collect additional user input relating to the neurostimulation treatment, with the task being customized to the patient based on the attributes of the user interactions; and control an interaction workflow to perform the task in the software platform.
    Type: Application
    Filed: February 28, 2024
    Publication date: September 12, 2024
    Inventors: Lisa Denise Moore, Bradley Lawrence Hershey
  • Publication number: 20240304317
    Abstract: A system to analyze patient location activity in connection with a neurostimulation treatment may: receive tagged location data associated with a patient undergoing the neurostimulation treatment, including tagged location data provided from a patient computing device that indicates a visit of the patient to one or more locations; identify a location type of the locations, using the tagged location data; determine characteristics of the visit at the location type, using the tagged location data; and control a workflow related to the neurostimulation treatment, based on the characteristics of the visit of the patient at the location type. In further examples, such workflows may include a patient interaction workflow, a caregiver workflow, or a clinician workflow, to generate tasks or provide informational alerts based on the patient location activity. Further examples are provided for closed-loop programming of a neurostimulation device based on the patient location activity.
    Type: Application
    Filed: February 28, 2024
    Publication date: September 12, 2024
    Inventors: Lisa Denise Moore, Bradley Lawrence Hershey
  • Publication number: 20240285951
    Abstract: A system to analyze data for neurostimulation programming may include capabilities to collect and analyze relevant input data (training data) for training a neurostimulation programming model. In an example, the system may: determine usage of a particular neurostimulation treatment, for a neurostimulation treatment that is associated with a set of parameters used by a neurostimulation device to deliver neurostimulation to a patient; evaluate patient feedback data (e.g., obtained from the patient) associated with the usage of the neurostimulation treatment; calculate, based on the patient feedback data, an amount of training data required to perform training operations on a programming selection model, with such training data being provided at least in part from the patient feedback data and optionally device data.
    Type: Application
    Filed: February 23, 2024
    Publication date: August 29, 2024
    Inventors: Dat Thanh Huynh, Matthew Lee McDonald, Bradley Lawrence Hershey, Kristen Marie Lechleiter
  • Publication number: 20240233912
    Abstract: Systems, devices, and methods for providing customizable interactive healthcare services in relation to neuromodulation treatment are disclosed. A digital health system includes a memory device that stores a database of device operation and treatment (DOT) information of neuromodulation device. The DOT information includes information releasable to a patient and device programming capability authorized to the patient, and can be categorized according to a plurality of pre-determined treatment phases and/or according to a plurality of pre-determined patient skill or engagement levels with the neuromodulation device. A processor determines a treatment phase and a skill or engagement level using patient state information, queries the database to determine personalized DOT information corresponding to the treatment phase and the patient skill or engagement level, and provides the personalized DOT information to the patient.
    Type: Application
    Filed: October 16, 2023
    Publication date: July 11, 2024
    Inventors: Kyle Harish Srivastava, Bradley Lawrence Hershey, Amarpreet Singh Bains
  • Publication number: 20240136050
    Abstract: Systems, devices, and methods for providing customizable interactive healthcare services in relation to neuromodulation treatment are disclosed. A digital health system includes a memory device that stores a database of device operation and treatment (DOT) information of neuromodulation device. The DOT information includes information releasable to a patient and device programming capability authorized to the patient, and can be categorized according to a plurality of pre-determined treatment phases and/or according to a plurality of pre-determined patient skill or engagement levels with the neuromodulation device. A processor determines a treatment phase and a skill or engagement level using patient state information, queries the database to determine personalized DOT information corresponding to the treatment phase and the patient skill or engagement level, and provides the personalized DOT information to the patient.
    Type: Application
    Filed: October 15, 2023
    Publication date: April 25, 2024
    Inventors: Kyle Harish Srivastava, Bradley Lawrence Hershey, Amarpreet Singh Bains
  • Patent number: 11957911
    Abstract: An example of a system for modulating neuroinflammation at a tissue site in a patient includes a neuromodulation output circuit, a memory, and a control circuit. The neuromodulation output circuit may be configured to deliver the neuromodulation. The memory may be configured to store a neuromodulation parameter set selected to modulate neural activity at the tissue site and a sensed biomarker parameter. The biomarker parameter may include a measure of a biomarker or a measure of a derivative of the biomarker. The biomarker may be indicative of the neuroinflammation at the tissue site. The control circuit may be configured to control the delivery of the neuromodulation using the neuromodulation parameter set and adjust one or more parameters of the neuromodulation parameter set using the biomarker parameter.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: April 16, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Bradley Lawrence Hershey, Changfang Zhu
  • Publication number: 20240057894
    Abstract: This document discusses systems, devices, and methods for monitoring and managing patients with chronic pain. A patient monitoring system comprises a sensor circuit to sense a physiological or functional signal indicative of or correlated to patient mobility, an electrostimulator to generate and deliver neuromodulation therapy to the patient, and a controller circuit to generate a mobility metric using the sensed physiological or functional signal. The mobility metric represents respective times spent in different activity intensity levels associated with one or more types of activities during a specific time period. The controller circuit can trend the mobility metric over time and determine a progress toward a personalized mobility goal of the patient, and control the electrostimulator to initiate or adjust the neuromodulation therapy in accordance with the trended mobility metric or the determined progress toward the mobility goal.
    Type: Application
    Filed: August 16, 2023
    Publication date: February 22, 2024
    Inventors: Kyle Harish Srivastava, Bradley Lawrence Hershey, Dat Thanh Huynh, Amarpreet Singh Bains, Matthew Lee McDonald, Benjamin Phillip Hahn, Kristen Marie Lechleiter
  • Patent number: 11904168
    Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating a volume of neural tissue, where the neural tissue has an activation function. The system may further include a neural modulation generator configured to deliver energy using at least some electrodes to generate a modulation field within the volume of neural tissue. The neural modulation generator may be configured to use a programmed modulation parameter set to generate the modulation field. The programmed modulation parameter set having values selected to control energy delivery using the at least some electrodes to achieve an objective function specific to the activation function of the volume of neural tissue to promote uniformity of a response to the modulation field in the volume of neural tissue along a span of the at least one lead.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: February 20, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, Bradley Lawrence Hershey, Michael A. Moffitt, Changfang Zhu
  • Publication number: 20240055085
    Abstract: Systems and techniques are disclosed to process freeform data relating to neurostimulation treatment of a human patient, to determine relevant attributes and information regarding a state of the patient. In an example, a system to process freeform data implements electronic operations to: obtain freeform input that indicates characteristics of a neurostimulation treatment of a human patient; validate the freeform input; identify attributes associated with a state of the human patient, based on words from the validated freeform input; associate the attributes with the validated freeform input; and store data for the validated freeform input and the associated attributes. Specific operations for validating may include excluding or replacing words, and specific operations for identifying attributes may be based on natural language processing. Such processing of the freeform data may be used to identify results of neurostimulation programs, and effect improvements to neurostimulation programming or usage.
    Type: Application
    Filed: August 1, 2023
    Publication date: February 15, 2024
    Inventors: Lisa Denise Moore, Bradley Lawrence Hershey
  • Patent number: 11801389
    Abstract: A neuromodulation customization system includes a field definition user interface, a neuromodulation signaling engine, and a supervisor engine. The field definition user interface is to facilitate entry of a customized electrotherapy field definition, with the field definition user interface including a set of input controls for defining field shape, field intensity, and field steering parameters of the customized electrotherapy field. The neuromodulation signaling engine is to produce commands for neuromodulation output circuitry to control generation of a customized electrotherapy field via a set of electrodes based on the customized electrotherapy field definition. The supervisor engine is to assess compliance of the customized electrotherapy field to be generated with applicable predefined criteria, and to modify generation of the customized electrotherapy field in response to an assessed non-compliance with the criteria.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: October 31, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Dheerendra Raghavendra Kashyap, Sarvani Grandhe, Natalie A. Brill, Bradley Lawrence Hershey, Changfang Zhu, Sridhar Kothandaraman, Dennis Zottola, Michael A. Moffitt
  • Publication number: 20230097509
    Abstract: A system may include at least one data collection platform and an event detector configured to detect an event. The at least one data collection platform may be configured for use to collect healthcare-related data at a defined data resolution for transfer to a data receiving system that may include one or more processors, at least one data input for receiving healthcare-related data, and memory for storing instructions for implementation by the one or more processors to collect healthcare-related data via the at least one data input. The at least one data collection platform may be configured to change the data resolution for collecting healthcare-related data in response to the detected event.
    Type: Application
    Filed: September 13, 2022
    Publication date: March 30, 2023
    Inventors: Kyle Harish Srivastava, Bradley Lawrence Hershey, Benjamin Phillip Hahn
  • Patent number: 11497917
    Abstract: A method of stimulating nerve tissue, a tissue stimulation system, and an external control device are provided. The method, system, and control device causes an electrical stimulus to be applied to at least one electrode adjacent the nerve tissue of a patient. The applied electrical stimulus comprises a plurality of pulses defined by a pulse width value and an amplitude value. The pulse amplitude value is increased (e.g., manually), and the pulse width value is automatically decreased in response to increasing the pulse amplitude value in a manner that increases the intensity of the applied electrical stimulus. Alternatively, the pulse width value may be decreased (e.g., manually), and the pulse amplitude value automatically increased in response to decreasing the pulse width value in a manner that increases the intensity of the applied electrical stimulus.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: November 15, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kerry Bradley, Bradley Lawrence Hershey, Dongchul Lee
  • Patent number: 11400294
    Abstract: An example of a neurostimulation system may include one or more sensing devices and a patient assistance device. The sensing device(s) may be configured to sense one or more signals from a patient and may include one or more non-invasive sensing devices. The patient assistance device may be configured to assist the patient in use of a stimulation device and may include a communication circuit configured to receive the sensed signal(s), a user interface configured to allow for interactions with the patient, and a processing circuit which may be configured to receive patient-specific information including the sensed signal(s), to analyze the patient-specific information with neurostimulation algorithm information representative of available therapeutic options, to produce one or more recommendations related to use of the stimulation device for treating the patient based on the analysis, and to present at least one recommendation using the user interface.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: August 2, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Matthew Lee McDonald, Bradley Lawrence Hershey, Dennis Zottola, Dat Thanh Huynh, Natalie Bloom Lyons, Juan Gabriel Hincapie Ordonez
  • Patent number: 11135438
    Abstract: A system for planning or conducting stimulation includes a display; and a processor that executes instructions configured for: displaying, on the display, a representation of a stimulation effect; obtaining and displaying, on the display, a path for migration of the stimulation effect; receiving a duration or rate for migration of the stimulation effect; and determining a selection of one of more electrodes or optical stimulators for one or more stimulation leads of a stimulation system to produce the stimulation effect and conduct the migration of the stimulation effect along the path according to the duration or rate.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: October 5, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Bradley Lawrence Hershey, Tianhe Zhang, Natalie A. Brill, Rosana Esteller, Jianwen Gu
  • Publication number: 20210275818
    Abstract: An example of a system for modulating neuroinflammation at a tissue site in a patient includes a neuromodulation output circuit, a memory, and a control circuit. The neuromodulation output circuit may be configured to deliver the neuromodulation. The memory may be configured to store a neuromodulation parameter set selected to modulate neural activity at the tissue site and a sensed biomarker parameter. The biomarker parameter may include a measure of a biomarker or a measure of a derivative of the biomarker. The biomarker may be indicative of the neuroinflammation at the tissue site. The control circuit may be configured to control the delivery of the neuromodulation using the neuromodulation parameter set and adjust one or more parameters of the neuromodulation parameter set using the biomarker parameter.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 9, 2021
    Inventors: Bradley Lawrence Hershey, Changfang Zhu
  • Patent number: 11040204
    Abstract: An example of a system for modulating neuroinflammation at a tissue site in a patient includes a neuromodulation output circuit, a memory, and a control circuit. The neuromodulation output circuit may be configured to deliver the neuromodulation. The memory may be configured to store a neuromodulation parameter set selected to modulate neural activity at the tissue site and a sensed biomarker parameter. The biomarker parameter may include a measure of a biomarker or a measure of a derivative of the biomarker. The biomarker may be indicative of the neuroinflammation at the tissue site. The control circuit may be configured to control the delivery of the neuromodulation using the neuromodulation parameter set and adjust one or more parameters of the neuromodulation parameter set using the biomarker parameter.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: June 22, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Bradley Lawrence Hershey, Changfang Zhu
  • Publication number: 20210016090
    Abstract: A neuromodulation targeting system includes a GUI that facilitates selection of one or more neuromodulation target regions. The GUI provides an interactive display representing anatomy of a patient with user-selectable portions corresponding to a plurality of predefined anatomical regions associated with distinct localized clinical effects of neuromodulation. The system further includes a targeting selector engine that is responsive to user selection of a first portion of the interactive display by configuring delivery of neuromodulation therapy to a first target region to produce a first localized clinical effect in the patient at a location corresponding to the first portion of the display, upon administration of the neuromodulation therapy to the patient.
    Type: Application
    Filed: October 7, 2020
    Publication date: January 21, 2021
    Inventors: Tianhe Zhang, Bradley Lawrence Hershey, Michael A. Moffitt
  • Publication number: 20200391040
    Abstract: A neuromodulation customization system includes a field definition user interface, a neuromodulation signaling engine, and a supervisor engine. The field definition user interface is to facilitate entry of a customized electrotherapy field definition, with the field definition user interface including a set of input controls for defining field shape, field intensity, and field steering parameters of the customized electrotherapy field. The neuromodulation signaling engine is to produce commands for neuromodulation output circuitry to control generation of a customized electrotherapy field via a set of electrodes based on the customized electrotherapy field definition. The supervisor engine is to assess compliance of the customized electrotherapy field to be generated with applicable predefined criteria, and to modify generation of the customized electrotherapy field in response to an assessed non-compliance with the criteria.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 17, 2020
    Inventors: Dheerendra Raghavendra Kashyap, Sarvari Grandhe, Natalie A. Brill, Bradley Lawrence Hershey, Changfang Zhu, Sridhar Kothandaraman, Dennis Zottola, Michael A. Moffitt
  • Patent number: 10850101
    Abstract: A neuromodulation targeting system includes a GUI that facilitates selection of one or more neuromodulation target regions. The GUI provides an interactive display representing anatomy of a patient with user-selectable portions corresponding to a plurality of predefined anatomical regions associated with distinct localized clinical effects of neuromodulation. The system further includes a targeting selector engine that is responsive to user selection of a first portion of the interactive display by configuring delivery of neuromodulation therapy to a first target region to produce a first localized clinical effect in the patient at a location corresponding to the first portion of the display, upon administration of the neuromodulation therapy to the patient.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: December 1, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Bradley Lawrence Hershey, Michael A. Moffitt
  • Patent number: 10806934
    Abstract: A neuromodulation customization system includes a field definition user interface, a neuromodulation signaling engine, and a supervisor engine. The field definition user interface is to facilitate entry of a customized electrotherapy field definition, with the field definition user interface including a set of input controls for defining field shape, field intensity, and field steering parameters of the customized electrotherapy field. The neuromodulation signaling engine is to produce commands for neuromodulation output circuitry to control generation of a customized electrotherapy field via a set of electrodes based on the customized electrotherapy field definition. The supervisor engine is to assess compliance of the customized electrotherapy field to be generated with applicable predefined criteria, and to modify generation of the customized electrotherapy field in response to an assessed non-compliance with the criteria.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: October 20, 2020
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Dheerendra Raghavendra Kashyap, Sarvani Grandhe, Natalie A. Brill, Bradley Lawrence Hershey, Changfang Zhu, Sridhar Kothandaraman, Dennis Zottola, Michael A. Moffitt